Perforin-mediated cytotoxicity in non-ST elevation myocardial infarction

Area of Science:

• Immunology
• Cardiology
• Cellular Biology

Background:

• Non-ST-segment elevation myocardial infarction (NSTEMI) involves complex inflammatory processes.
• Perforin-mediated cytotoxicity plays a role in immune cell function and tissue damage.
• Understanding the role of perforin in NSTEMI is crucial for managing myocardial injury.

Purpose of the Study:

• To investigate the role of perforin (P)-mediated cytotoxicity in myocardial tissue damage in NSTEMI patients.
• To analyze the dynamics of perforin-expressing lymphocytes in NSTEMI patients treated with anti-ischaemic drugs.

Main Methods:

• Study included 48 NSTEMI patients.
• Flow cytometry was used to quantify perforin-expressing lymphocytes (P(+) cells) in peripheral blood.
• Correlations were assessed between cardiac troponin I levels and P(+) cell frequencies.
• Perforin-mediated cytotoxicity was measured using K-562 target cells.

Main Results:

• Elevated P(+) lymphocytes, particularly in natural killer (NK), T, and NKT cell subsets, were observed on day 1 post-NSTEMI compared to controls.
• Positive correlations were found between cardiac troponin I and frequencies of P(+) cells, P(+) T cells, and P(+) NK cells.
• Perforin expression in NK cells correlated with cytotoxicity, although this was partially reduced by day 21.
• CD56(+) lymphocytes were detected in damaged myocardium, suggesting tissue infiltration.

Conclusions:

• NSTEMI patients exhibit a significant and prolonged systemic inflammatory reaction mediated by perforin.
• This sustained inflammatory response may contribute to autoaggressive reactions against myocardial tissue.
• Perforin-mediated cytotoxicity is a key factor in the inflammatory dynamics following NSTEMI.